Allergychoices Approach: Allergychoices helps employers reduce the costs and impact of chronic allergic diseases (allergies, asthma, chronic sinusitis, eczema, etc.) through a custom diagnostic and allergy drop treatment program (using the La Crosse Method™ Protocol). The Allergy Control Program integrates easily with onsite/nearsite/DPC clinic workflows. This disease-modifying treatment helps reduce short- and long-term spend and improve employee health and productivity; and it fully addresses quadruple aim goals. Many people don't realize allergic diseases impact one in five employees -costs add up quickly!
How we help employers: We help employers reduce spend, increase productivity and decrease absenteeism from allergic diseases through onsite/nearsite/primary & DPC care clinics. By training these providers, we help them treat rather than refer to specialists, enhance patient engagement, adherence, and continuity of care. Patients take tailored treatment at home, reducing time away from work. Because treatment changes the underlying disease, patients often reduce or eliminate many chronic allergic diseases that drive long-term costs, as well as reduce medications including those that impact productivity (sedating antihistamines are notorious for this). Protocol outcomes have been validated through the Validation Institute.
Cognivue® is the world's first FDA-cleared test of cognitive function. Cognivue objectively, quantitatively and reliably identifies changes in cognitive function that could be indicative of an impairment that you may optimally treat or manage. It's personalized, consistent and reliable.
The health care system tests routinely for conditions such as cervical cancer, diabetes, cholesterol, colon cancer, etc., but there is no consistent standard of care around cognitive health testing. Cognitive testing is often performed too late when cognitive functions are moderate or severely impaired. In addition, current cognitive testing consists of simple decade-old tests performed either with paper and pencil or embedded in a computer. Cognivue elevates the current standard of care as it relates to cognitive testing.
Health City Cayman Islands is transforming healthcare and changing lives. Accredited by Joint Commission International (JCI), HCCI offers a combination of expertise, technological innovation, and compassionate, holistic care that results in exceptional outcomes. We provide world class specialized care in orthopedics, neurology and spinal surgery, cardiology, bariatric surgery, cancer care and much more.
For further information, visit www.healthcitycaymanislands.com.
Doing now what patients need next. A pioneer in the development of blood glucose monitoring and insulin delivery systems, Roche Diabetes Care is committed to helping people with diabetes live lives that are as normal and active as possible and helping healthcare professionals manage their patients' condition in an optimal way. The ACCU-CHEK® portfolio-from blood glucose monitoring through information management to insulin delivery - offers innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management.
Accurate and precise body composition - Styku provides DEXA-quality body composition with medical grade accuracy and consistency at an affordable price and in a non-invasive experience. Using the latest AI technology, Styku Phoenix can predict your fat mass, bone mass, lean muscle, visceral fat, and more. www. Styku.com